Human Studies Review Board (HSRB); Notification of Public Meetings, 71637-71638 [2021-27396]
Download as PDF
Federal Register / Vol. 86, No. 240 / Friday, December 17, 2021 / Notices
I. General Information
A. Does this action apply to me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. The following
list of North American Industrial
Classification System (NAICS) codes is
not intended to be exhaustive, but rather
provides a guide to help readers
determine whether this document
applies to them. Potentially affected
entities may include:
• Crop production (NAICS code 111).
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
jspears on DSK121TN23PROD with NOTICES1
B. What should I consider as I prepare
my comments for EPA?
1. Submitting CBI. Do not submit this
information to EPA through
regulations.gov or email. Clearly mark
the part or all of the information that
you claim to be CBI. For CBI
information in a disk or CD–ROM that
you mail to EPA, mark the outside of the
disk or CD–ROM as CBI and then
identify electronically within the disk or
CD–ROM the specific information that
is claimed as CBI. In addition to one
complete version of the comment that
includes information claimed as CBI, a
copy of the comment that does not
contain the information claimed as CBI
must be submitted for inclusion in the
public docket. Information so marked
will not be disclosed except in
accordance with procedures set forth in
40 CFR part 2.
2. Tips for preparing your comments.
When preparing and submitting your
comments, see the commenting tips at
https://www.epa.gov/dockets/
commenting-epa-dockets.
II. Registration Applications
EPA has received applications to
register pesticide products containing
active ingredients not included in any
currently registered pesticide products.
Pursuant to the provisions of FIFRA
section 3(c)(4) (7 U.S.C. 136a(c)(4)), EPA
is hereby providing notice of receipt and
opportunity to comment on these
applications. Notice of receipt of these
applications does not imply a decision
by the Agency on these applications.
For actions being evaluated under EPA’s
public participation process for
registration actions, there will be an
additional opportunity for public
comment on the proposed decisions.
Please see EPA’s public participation
website for additional information on
this process (https://www2.epa.gov/
pesticide-registration/public-
VerDate Sep<11>2014
17:39 Dec 16, 2021
Jkt 256001
participation-process-registrationactions).
A. Notice of Receipt—New Active
Ingredients
1. File Symbols: 52991–GL and
51934–ET. Docket ID number: EPA–
HQ–OPP–2021–0651. Applicant: Spring
Regulatory Sciences on behalf of
Bedoukian Research, Inc., 21 Finance
Drive, Danbury, CT 06810–4192.
Product name: Bedoukian Serricornin
Technical Pheromone and Cidetrak CB.
Active ingredient: Mating disruptant,
rac–4S,6S,7S–serricornin at 63.0% and
5.0% by weight, respectively. Proposed
classification/Use: Mating disruption for
cigarette beetle, lasioderma serricorne.
Contact: BPPD.
2. File Symbol: 91283–RE. Docket ID
number: EPA–HQ–OPP–2021–0786.
Applicant: Amoe´ba SA 38 Avenue des
Fre`res Montgolfier, F–69680 Chassieu,
France (c/o SciReg, Inc. 12733 Director’s
Loop, Woodbridge, VA 22192). Product
name: Amoe´ba EP #2. Active ingredient:
Antimicrobial—Willaertia Magna
C2c.Maky at 1%. Proposed use: For
control of microbial slime (bioslime),
microbially induced non-public health
corrosion and non-public health general
microbial flora in cooling towers waters.
Contact: BPPD.
3. File Symbol: 91283–RG. Docket ID
number: EPA–HQ–OPP–2021–0786.
Applicant: Amoe´ba SA 38 Avenue des
Fre`res Montgolfier, F–69680 Chassieu,
France (c/o SciReg, Inc. 12733 Director’s
Loop, Woodbridge, VA 22192). Product
name: Amoe´ba EP #1. Active ingredient:
Antimicrobial—Willaertia Magna
C2c.Maky at 1%. Proposed use: For
control of microbial slime (bioslime),
microbially induced non-public health
corrosion and non-public health general
microbial flora in cooling towers waters.
Contact: BPPD.
4. File Symbol: 91283–RN. Docket ID
number: EPA–HQ–OPP–2021–0786.
Applicant: Amoe´ba SA 38 Avenue des
Fre`res Montgolfier, F–69680 Chassieu,
France (c/o SciReg, Inc. 12733 Director’s
Loop, Woodbridge, VA 22192). Product
name: Amoe´ba TGAI. Active ingredient:
Antimicrobial—Willaertia Magna
C2c.Maky at 1%. Proposed use: For
control of microbial slime (bioslime),
microbially induced non-public health
corrosion and non-public health general
microbial flora in cooling towers waters.
Contact: BPPD.
5. File Symbol: 91283–RR. Docket ID
number: EPA–HQ–OPP–2021–0786.
Applicant: Amoe´ba SA 38 Avenue des
Fre`res Montgolfier, F–69680 Chassieu,
France (c/o SciReg, Inc. 12733 Director’s
Loop, Woodbridge, VA 22192). Product
name: Amoe´ba EP #3. Active ingredient:
Antimicrobial—Willaertia Magna
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
71637
C2c.Maky at 1%. Proposed use: For
control of microbial slime (bioslime),
microbially induced non-public health
corrosion and non-public health general
microbial flora in cooling towers waters.
Contact: BPPD.
Authority: 7 U.S.C. 136 et seq.
Dated: December 7, 2021.
Delores Barber,
Director, Information Technology and
Resources Management Division, Office of
Program Support.
[FR Doc. 2021–27301 Filed 12–16–21; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[ER–FRL–9059–8]
Environmental Impact Statements;
Notice of Availability
Responsible Agency: Office of Federal
Activities, General Information 202–
564–5632 or https://www.epa.gov/nepa.
Weekly receipt of Environmental Impact
Statements (EIS)
Filed December 6, 2021 10 a.m. EST
Through December 13, 2021 10 a.m.
EST
Pursuant to 40 CFR 1506.9.
Notice
Section 309(a) of the Clean Air Act
requires that EPA make public its
comments on EISs issued by other
Federal agencies. EPA’s comment letters
on EISs are available at: https://
cdxnodengn.epa.gov/cdx-enepa-public/
action/eis/search.
EIS No. 20210184, Final, USFS, OR,
Stella Landscape Restoration Project,
Review Period Ends: 01/31/2022,
Contact: Michelle Calvert 541–441–
7059.
Dated: December 13, 2021.
Cindy S. Barger,
Director, NEPA Compliance Division, Office
of Federal Activities.
[FR Doc. 2021–27336 Filed 12–16–21; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
[FRL–9328–01–ORD]
Human Studies Review Board (HSRB);
Notification of Public Meetings
Environmental Protection
Agency (EPA).
ACTION: Notice of public meeting.
AGENCY:
The Environmental Protection
Agency (EPA), Office of Research and
Development (ORD), gives notice of the
SUMMARY:
E:\FR\FM\17DEN1.SGM
17DEN1
71638
Federal Register / Vol. 86, No. 240 / Friday, December 17, 2021 / Notices
2022 public meetings of the Human
Studies Review Board (HSRB). The
HSRB provides advice, information, and
recommendations on issues related to
scientific and ethical aspects of thirdparty human subjects’ research that are
submitted to the Office of Pesticide
Programs (OPP) to be used for regulatory
purposes.
DATES: Four three-day virtual public
meetings will be held on:
1. January 25–27, 2022;
2. April 26–28, 2022;
3. July 19–21, 2022; and
4. October 25–27, 2022.
Meetings will be held each day from
1 p.m. to 5 p.m. Eastern Time. For each
meeting, separate subsequent follow-up
meetings are planned for the HSRB to
finalize reports from the three-day
meetings. These meetings will be held
from 2 p.m. to 4 p.m. Eastern time on
the following dates: March 17, 2022;
June 16, 2022; September 14, 2022; and
December 14, 2022.
ADDRESSES: These meetings are open to
the public and will be conducted
entirely virtually and by telephone. For
detailed access information and meeting
materials please visit the HSRB website:
https://www.epa.gov/osa/humanstudies-review-board.
FOR FURTHER INFORMATION CONTACT: Any
member of the public who wished to
receive further information should
contact the HSRB Designated Federal
Official (DFO), Tom Tracy, via phone/
voicemail at: 919–541–4334; or via
email at: tracy.tom@epa.gov.
SUPPLEMENTARY INFORMATION:
jspears on DSK121TN23PROD with NOTICES1
Background
The HSRB is a Federal advisory
committee operating in accordance with
the Federal Advisory Committee Act 5
U.S.C. App.2 section 9. The HSRB
provides advice, information, and
recommendations on issues related to
scientific and ethical aspects of thirdparty human subjects research that are
submitted to the Office of Pesticide
Programs (OPP) to be used for regulatory
purposes.
Meeting access: These meetings will
be open to the public. The full agenda
with access information and meeting
materials will be available seven
calendar days prior to the start of each
meeting at the HSRB website: https://
www.epa.gov/osa/human-studiesreview-board. For questions on
document availability, or if you do not
have access to the internet, consult with
the DFO, Tom Tracy listed under FOR
FURTHER INFORMATION CONTACT.
Special Accommodations. For
information on access or services for
individuals with disabilities, or to
VerDate Sep<11>2014
17:39 Dec 16, 2021
Jkt 256001
request accommodation of a disability,
please contact the DFO listed under FOR
FURTHER INFORMATION CONTACT at least
10 days prior to each meeting to give
EPA as much time as possible to process
your request.
How may I participate in this meeting?
The HSRB encourages the public’s
input. You may participate in these
meetings by following the instructions
in this section.
1. Oral comments. To pre-register to
make oral comments, please contact the
DFO, Tom Tracy, listed under FOR
FURTHER INFORMATION CONTACT. Requests
to present oral comments during the
meetings will be accepted up to Noon
Eastern Time, seven calendar days prior
to each meeting date. To the extent that
time permits, interested persons who
have not pre-registered may be
permitted by the HSRB Chair to present
oral comments during the meetings at
the designated time on the agenda. Oral
comments before the HSRB are
generally limited to five minutes per
individual or organization. If additional
time is available, further public
comments may be possible.
2. Written comments. For the Board to
have the best opportunity to review and
consider your comments as it
deliberates, you should submit your
comments prior to the meetings via
email by Noon Eastern Time, seven
calendar days prior to each meeting
date. If you submit comments after these
dates, those comments will be provided
to the HSRB members, but you should
recognize that the HSRB members may
not have adequate time to consider your
comments prior to their discussion. You
should submit your comments to the
DFO, Tom Tracy listed under FOR
FURTHER INFORMATION CONTACT. There is
no limit on the length of written
comments for consideration by the
HSRB.
Topics for discussion. The agenda and
meeting materials will be available
seven calendar days in advance of each
meeting at https://www.epa.gov/osa/
human-studies-review-board.
Meeting minutes and final reports.
Minutes of these meetings, summarizing
the topics discussed and
recommendations made by the HSRB,
will be released within 90 calendar days
of each meeting. These minutes will be
available at https://www.epa.gov/osa/
human-studies-review-board. In
addition, information regarding the
HSRB’s Final Reports, will be found at
https://www.epa.gov/osa/humanstudies-review-board or can be
PO 00000
Frm 00026
Fmt 4703
Sfmt 9990
requested from Tom Tracy listed under
FOR FURTHER INFORMATION CONTACT.
Mary Ross,
Director, Office of Science Advisor, Policy
and Engagement.
[FR Doc. 2021–27396 Filed 12–16–21; 8:45 am]
BILLING CODE 6560–50–P
FEDERAL DEPOSIT INSURANCE
CORPORATION
Designated Reserve Ratio for 2022
Federal Deposit Insurance
Corporation.
AGENCY:
Notice of Designated Reserve
Ratio for 2022.
ACTION:
Pursuant to the Federal
Deposit Insurance Act (FDI Act), the
Board of Directors of the Federal
Deposit Insurance Corporation
designates that the Designated Reserve
Ratio (DRR) for the Deposit Insurance
Fund shall remain at 2 percent for 2022.
The Board is publishing this notice as
required by section 7(b)(3)(A)(i) the FDI
Act (12 U.S.C. 1817(b)(3)(A)(i)).
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Ashley Mihalik, Chief, Banking and
Regulatory Policy Section, Division of
Insurance and Research, (202) 898–
3793, amihalik@fdic.gov; Daniel
Hoople, Acting Chief, Fund Analysis
and Pricing Section, Division of
Insurance and Research, (202) 898–
3835, dhoople@fdic.gov; or Nefretete
Smith, Counsel, Legal Division, (202)
898–6851, nefsmith@fdic.gov.
Pursuant
to the FDI Act, the Board designates that
the DRR for the Deposit Insurance Fund
shall remain at 2 percent for 2022. The
Board is publishing this notice as
required by section 7(b)(3)(A)(i) the FDI
Act (12 U.S.C. 1817(b)(3)(A)(i)). There is
no need to amend 12 CFR 327.4(g), the
section of the FDIC’s regulations which
sets forth the DRR, because the DRR for
2022 is the same as the current DRR.
SUPPLEMENTARY INFORMATION:
Dated at Washington, DC, on December 14,
2021.
Federal Deposit Insurance Corporation.
By order of the Board of Directors.
James P. Sheesley,
Assistant Executive Secretary.
[FR Doc. 2021–27382 Filed 12–16–21; 8:45 am]
BILLING CODE 6714–01–P
E:\FR\FM\17DEN1.SGM
17DEN1
Agencies
[Federal Register Volume 86, Number 240 (Friday, December 17, 2021)]
[Notices]
[Pages 71637-71638]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-27396]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
[FRL-9328-01-ORD]
Human Studies Review Board (HSRB); Notification of Public
Meetings
AGENCY: Environmental Protection Agency (EPA).
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: The Environmental Protection Agency (EPA), Office of Research
and Development (ORD), gives notice of the
[[Page 71638]]
2022 public meetings of the Human Studies Review Board (HSRB). The HSRB
provides advice, information, and recommendations on issues related to
scientific and ethical aspects of third-party human subjects' research
that are submitted to the Office of Pesticide Programs (OPP) to be used
for regulatory purposes.
DATES: Four three-day virtual public meetings will be held on:
1. January 25-27, 2022;
2. April 26-28, 2022;
3. July 19-21, 2022; and
4. October 25-27, 2022.
Meetings will be held each day from 1 p.m. to 5 p.m. Eastern Time.
For each meeting, separate subsequent follow-up meetings are planned
for the HSRB to finalize reports from the three-day meetings. These
meetings will be held from 2 p.m. to 4 p.m. Eastern time on the
following dates: March 17, 2022; June 16, 2022; September 14, 2022; and
December 14, 2022.
ADDRESSES: These meetings are open to the public and will be conducted
entirely virtually and by telephone. For detailed access information
and meeting materials please visit the HSRB website: https://www.epa.gov/osa/human-studies-review-board.
FOR FURTHER INFORMATION CONTACT: Any member of the public who wished to
receive further information should contact the HSRB Designated Federal
Official (DFO), Tom Tracy, via phone/voicemail at: 919-541-4334; or via
email at: [email protected].
SUPPLEMENTARY INFORMATION:
Background
The HSRB is a Federal advisory committee operating in accordance
with the Federal Advisory Committee Act 5 U.S.C. App.2 section 9. The
HSRB provides advice, information, and recommendations on issues
related to scientific and ethical aspects of third-party human subjects
research that are submitted to the Office of Pesticide Programs (OPP)
to be used for regulatory purposes.
Meeting access: These meetings will be open to the public. The full
agenda with access information and meeting materials will be available
seven calendar days prior to the start of each meeting at the HSRB
website: https://www.epa.gov/osa/human-studies-review-board. For
questions on document availability, or if you do not have access to the
internet, consult with the DFO, Tom Tracy listed under FOR FURTHER
INFORMATION CONTACT.
Special Accommodations. For information on access or services for
individuals with disabilities, or to request accommodation of a
disability, please contact the DFO listed under FOR FURTHER INFORMATION
CONTACT at least 10 days prior to each meeting to give EPA as much time
as possible to process your request.
How may I participate in this meeting?
The HSRB encourages the public's input. You may participate in
these meetings by following the instructions in this section.
1. Oral comments. To pre-register to make oral comments, please
contact the DFO, Tom Tracy, listed under FOR FURTHER INFORMATION
CONTACT. Requests to present oral comments during the meetings will be
accepted up to Noon Eastern Time, seven calendar days prior to each
meeting date. To the extent that time permits, interested persons who
have not pre-registered may be permitted by the HSRB Chair to present
oral comments during the meetings at the designated time on the agenda.
Oral comments before the HSRB are generally limited to five minutes per
individual or organization. If additional time is available, further
public comments may be possible.
2. Written comments. For the Board to have the best opportunity to
review and consider your comments as it deliberates, you should submit
your comments prior to the meetings via email by Noon Eastern Time,
seven calendar days prior to each meeting date. If you submit comments
after these dates, those comments will be provided to the HSRB members,
but you should recognize that the HSRB members may not have adequate
time to consider your comments prior to their discussion. You should
submit your comments to the DFO, Tom Tracy listed under FOR FURTHER
INFORMATION CONTACT. There is no limit on the length of written
comments for consideration by the HSRB.
Topics for discussion. The agenda and meeting materials will be
available seven calendar days in advance of each meeting at https://www.epa.gov/osa/human-studies-review-board.
Meeting minutes and final reports. Minutes of these meetings,
summarizing the topics discussed and recommendations made by the HSRB,
will be released within 90 calendar days of each meeting. These minutes
will be available at https://www.epa.gov/osa/human-studies-review-board. In addition, information regarding the HSRB's Final Reports,
will be found at https://www.epa.gov/osa/human-studies-review-board or
can be requested from Tom Tracy listed under FOR FURTHER INFORMATION
CONTACT.
Mary Ross,
Director, Office of Science Advisor, Policy and Engagement.
[FR Doc. 2021-27396 Filed 12-16-21; 8:45 am]
BILLING CODE 6560-50-P